BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pieri A, Harvey J, Bundred N. Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice? World J Clin Oncol 2014; 5(3): 546-553 [PMID: 25114868 DOI: 10.5306/wjco.v5.i3.546]
URL: https://www.wjgnet.com/2218-4333/full/v5/i3/546.htm
Number Citing Articles
1
Meghan R. Flanagan, Mara H. Rendi, Kristine E. Calhoun, Benjamin O. Anderson, Sara H. Javid. Pleomorphic Lobular Carcinoma In Situ: Radiologic–Pathologic Features and Clinical ManagementAnnals of Surgical Oncology 2015; 22(13): 4263 doi: 10.1245/s10434-015-4552-x
2
Abeer Shaaban. Breast Pathology2017; : 77 doi: 10.1007/978-3-319-28655-6_6
3
Umar Wazir, Ali Wazir, Clive Wells, Kefah Mokbel. Pleomorphic lobular carcinoma in situ: Current evidence and a systemic reviewOncology Letters 2016; 12(6): 4863 doi: 10.3892/ol.2016.5331
4
Daniel I. Hoffman, Paul J. Zhang, Julia Tchou. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experienceSurgical Oncology 2019; 28: 190 doi: 10.1016/j.suronc.2019.01.009
5
Anthony J. Maxwell, Karen Clements, David J. Dodwell, Andrew J. Evans, Adele Francis, Monuwar Hussain, Julie Morris, Sarah E. Pinder, Elinor J. Sawyer, Jeremy Thomas, Alastair Thompson. The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane ProjectThe Breast 2016; 27: 109 doi: 10.1016/j.breast.2016.03.004
6
Elizabeth M. Ward, Carol E. DeSantis, Chun Chieh Lin, Joan L. Kramer, Ahmedin Jemal, Betsy Kohler, Otis W. Brawley, Ted Gansler. Cancer statistics: Breast cancer in situCA: A Cancer Journal for Clinicians 2015; 65(6): 481 doi: 10.3322/caac.21321
7
Julia L. Savage, Deborah O. Jeffries, Mitra Noroozian, Michael S. Sabel, Julie M. Jorns, Mark A. Helvie. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical OutcomesAmerican Journal of Roentgenology 2018; 211(2): 462 doi: 10.2214/AJR.17.19088
8
Abeer M. Shaaban. Why is LCIS Important—Pathological ReviewCurrent Breast Cancer Reports 2021; 13(3): 132 doi: 10.1007/s12609-021-00415-1
9
Kamaljeet Singh, Cherie Paquette, Elizabeth T. Kalife, Yihong Wang, Shamlal Mangray, M. Ruhul Quddus, Margaret M. Steinhoff. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypesHuman Pathology 2018; 78: 163 doi: 10.1016/j.humpath.2018.04.026
10
Batul Al-zubeidy, Nora Hansen. Atypical Breast Proliferative Lesions and Benign Breast Disease2018; : 89 doi: 10.1007/978-3-319-92657-5_7
11
Amita A. Desai, Rafael E. Jimenez, Tanya L. Hoskin, Courtney N. Day, Judy C. Boughey, Tina J. Hieken. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the BreastAnnals of Surgical Oncology 2018; 25(10): 3064 doi: 10.1245/s10434-018-6591-6
12
Gyula Pekar. Encyclopedia of PathologyEncyclopedia of Pathology 2018; : 1 doi: 10.1007/978-3-319-28845-1_4722-1
13
Gyula Pekar. Breast PathologyEncyclopedia of Pathology 2020; : 251 doi: 10.1007/978-3-319-62539-3_4722
14
Supriya Bevinakoppamath, Adel Mohammed Saleh Ahmed, Shobha Chikkavaddaraguddi Ramachandra, Prashant Vishwanath, Akila Prashant. Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast CancerFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.618172
15
Carolina E. Fasola, Jie Jane Chen, Kristin C. Jensen, Kimberly H. Allison, Kathleen C. Horst. Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breastThe Breast Journal 2018; 24(1): 66 doi: 10.1111/tbj.12843
16
Yazan A. Masannat, Ehab Husain, Rebecca Roylance, Steven D. Heys, Pauline J Carder, Hiam Ali, Yasmine Maurice, Sarah E. Pinder, Elinor Sawyer, Abeer M. Shaaban. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situThe Breast 2018; 38: 120 doi: 10.1016/j.breast.2017.12.011
17
Lauren Q. Chang Sen, Wendie A. Berg, Regina J. Hooley, Gloria J. Carter, Mohamed M. Desouki, Jules H. Sumkin. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular HyperplasiaAmerican Journal of Roentgenology 2016; 207(5): 1132 doi: 10.2214/AJR.15.15425
18
Helena Hwang, Sunati Sahoo. A Comprehensive Guide to Core Needle Biopsies of the Breast2016; : 561 doi: 10.1007/978-3-319-26291-8_14
19
Paula S. Ginter, Timothy M. D'Alfonso. Current Concepts in Diagnosis, Molecular Features, and Management of Lobular Carcinoma In Situ of the Breast With a Discussion of Morphologic VariantsArchives of Pathology & Laboratory Medicine 2017; 141(12): 1668 doi: 10.5858/arpa.2016-0421-RA
20
Megan L. Troxell, Yun An Chen, Jing Yu, Debra M. Ikeda, Kimberly H. Allison. Practical Breast Pathology2019; : 73 doi: 10.1007/978-3-030-16518-5_4
21
Maria P. Foschini, Rossella Miglio, Roberta Fiore, Chiara Baldovini, Isabella Castellano, Grace Callagy, Simonetta Bianchi, Handan Kaya, Isabel Amendoeira, Patrizia Querzoli, Francesca Poli, Cristian Scatena, Alicia Cordoba, Francesca Pietribiasi, Anikó Kovács, Hana Faistova, Gábor Cserni, Cecily Quinn. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literatureEuropean Journal of Surgical Oncology 2019; 45(12): 2279 doi: 10.1016/j.ejso.2019.07.011
22
Rachel F. Brem, Anita K. Mehta, Grace M. Thomas. High-Risk Lesions at Minimally Invasive Breast Biopsy: Now What?Current Radiology Reports 2017; 5(9) doi: 10.1007/s40134-017-0238-4
23
Sarah E. Pinder, Abeer M. Shaaban. Breast Cancer Management for Surgeons2018; : 103 doi: 10.1007/978-3-319-56673-3_10
24
Sarah E. Pinder, Abeer M. Shaaban. In situ lobular proliferations of the breastDiagnostic Histopathology 2018; 24(2): 58 doi: 10.1016/j.mpdhp.2017.12.004
25
Stephanie M. Wong, Tari King, Jean-Francois Boileau, William T. Barry, Mehra Golshan. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In SituAnnals of Surgical Oncology 2017; 24(9): 2509 doi: 10.1245/s10434-017-5867-6
26
Mary Ann Sanders, Stephanie M. Wong, Julian Bryan Iorgulescu, Susan C. Lester. Changes and Clarifications in the Eighth Edition of the AJCC Cancer Staging System for Breast CancerAJSP: Reviews and Reports 2018; 23(3): 113 doi: 10.1097/PCR.0000000000000239